Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

NCT02022293 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

324

Enrollment

OTHER

Sponsor class

Stopped Enrollment target could not be achieved.

Conditions

Nasopharyngeal Carcinoma
Radiation Therapy Complication

Interventions

DRUG: Atorvastatin
OTHER: Placebo

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University